Osborne A - Search Results

1

Occurrence of the Cys311 DRD2 variant in a pedigree multiply affected with panic disorder.

Crawford F, Hoyne J, Diaz P, Osborne A, Dorotheo J, Sheehan D, Mullan M. Crawford F, et al. Among authors: osborne a. Am J Med Genet. 1995 Aug 14;60(4):332-4. doi: 10.1002/ajmg.1320600414. Am J Med Genet. 1995. PMID: 7485271

2

Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer's Disease but is not causative.

Bennett C, Crawford F, Osborne A, Diaz P, Hoyne J, Lopez R, Roques P, Duara R, Rossor M, Mullan M. Bennett C, et al. Among authors: osborne a. Am J Med Genet. 1995 Feb 27;60(1):1-6. doi: 10.1002/ajmg.1320600102. Am J Med Genet. 1995. PMID: 7485228

3

Dopamine DRD2/Cys311 is not associated with chronic schizophrenia.

Crawford F, Hoyne J, Cai X, Osborne A, Poston D, Zaglul J, Dajani N, Walsh S, Bradley R, Solomon R, Mullan M. Crawford F, et al. Among authors: osborne a. Am J Med Genet. 1996 Sep 20;67(5):483-4. doi: 10.1002/(SICI)1096-8628(19960920)67:5<483::AID-AJMG8>3.0.CO;2-L. Am J Med Genet. 1996. PMID: 8886166

4

Familial and population-based studies of apolipoprotein E and Alzheimer's disease.

Mullan M, Scibelli P, Duara R, Fallin D, Gold M, Schinka J, Hoyne J, Osborne A, Sevush S, Crawford F. Mullan M, et al. Among authors: osborne a. Ann N Y Acad Sci. 1996 Dec 16;802:16-26. doi: 10.1111/j.1749-6632.1996.tb32594.x. Ann N Y Acad Sci. 1996. PMID: 8993480

5

Association of apolipoprotein E but not B with Alzheimer's disease.

Poduslo SE, Riggs D, Schwankhaus J, Osborne A, Crawford F, Mullan M. Poduslo SE, et al. Among authors: osborne a. Hum Genet. 1995 Nov;96(5):597-600. doi: 10.1007/BF00197418. Hum Genet. 1995. PMID: 8530010

6

Retinoblastoma protein expression facilitates chromatin remodeling at the HLA-DRA promoter.

Osborne A, Tschickardt M, Blanck G. Osborne A, et al. Nucleic Acids Res. 1997 Dec 15;25(24):5095-102. doi: 10.1093/nar/25.24.5095. Nucleic Acids Res. 1997. PMID: 9396821 Free PMC article.

7

Activation of a methylated promoter mediated by a sequence-specific DNA-binding protein, RFX.

Niesen MI, Osborne AR, Yang H, Rastogi S, Chellappan S, Cheng JQ, Boss JM, Blanck G. Niesen MI, et al. J Biol Chem. 2005 Nov 25;280(47):38914-22. doi: 10.1074/jbc.M504633200. Epub 2005 Sep 15. J Biol Chem. 2005. PMID: 16166088 Free article.

8

Oct-1 DNA binding activity unresponsive to retinoblastoma protein expression prevents MHC class II induction in a non-small cell lung carcinoma cell line.

Osborne AR, Zhang H, Blanck G. Osborne AR, et al. Mol Immunol. 2006 Feb;43(6):710-6. doi: 10.1016/j.molimm.2005.03.013. Epub 2005 Apr 14. Mol Immunol. 2006. PMID: 16360016

9

Technological advances in the study of HLA-DRA promoter regulation: extending the functions of CIITA, Oct-1, Rb, and RFX.

Niesen MI, Osborne AR, Lagor WR, Zhang H, Kazemfar K, Ness GC, Blanck G. Niesen MI, et al. Acta Biochim Biophys Sin (Shanghai). 2009 Mar;41(3):198-205. doi: 10.1093/abbs/gmp002. Acta Biochim Biophys Sin (Shanghai). 2009. PMID: 19280058 Free article.

10

Oct-1 maintains an intermediate, stable state of HLA-DRA promoter repression in Rb-defective cells: an Oct-1-containing repressosome that prevents NF-Y binding to the HLA-DRA promoter.

Osborne AR, Zhang H, Fejer G, Palubin KM, Niesen MI, Blanck G. Osborne AR, et al. J Biol Chem. 2004 Jul 9;279(28):28911-9. doi: 10.1074/jbc.M403118200. Epub 2004 Apr 22. J Biol Chem. 2004. PMID: 15105429 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

507 results

Search Page

Filters